jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Pharmacology and PharmacotherapeuticsNOW IN
Article

Effect of Atorvastatin and Rosuvastatin on the Glycemic Control in Patients with Type II Diabetes Mellitus: A Comparative, Randomized, Double-Blind Study

Mohini Sachin Mahatme1, Mukunda Bharat Bargade1★, Sachin K. Hiware1, M. M. Motlag2★ Corresponding author

  1. 1Department of Pharmacology, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India.
  2. 2Department of Medicine, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India.

CORRESPONDENCE

Mukunda Bharat Bargade

Department of Pharmacology, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India.

mukundagmc@gmail.com

Received: 22-01-2021; Revised: 15-05-2021; Accepted: 22-05-2021.

Volume 12, Issue 2 · pp. 54–60 · PUBLISHED 17 September 2021 · DOI: 10.4103/jpp.jpp_8_21

View on JPP original site ↗

ABSTRACT

Objectives: To compare the effects of atorvastatin and rosuvastatin in type II diabetes mellitus (T2DM) patients with dyslipidemia. Materials and Methods: Eighty patients with history of T2DM of more than 3 months duration, glycated hemoglobin <7%, dyslipidemia, and normal electrocardiogram were included in the randomized double‑blind trial. The patients received either tablet atorvastatin 20 mg or rosuvastatin 10 mg once a day along with metformin and glimepiride twice daily orally. Patients were evaluated by the change in estimated average glucose (eAG), lipid profile, and incidence of adverse drug reactions (ADRs). Results: Rise in fasting blood sugar (FBS), postprandial blood sugar, and eAG were significant in the atorvastatin group as compared to the rosuvastatin group where there was a significant increase only in FBS levels. Changes in lipid parameters and incidence of ADR were similar in both the groups. Conclusion: Rosuvastatin can be preferred to atorvastatin in T2DM with dyslipidemia due to less variation in the blood sugar parameters, effective control over lipid profile, pleiotropic effects, and less microsomal interactions.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Mahatme, M. S., Bargade, M. B., Hiware, S. K., & Motlag, M. M. (2021). Effect of Atorvastatin and Rosuvastatin on the Glycemic Control in Patients with Type II Diabetes Mellitus: A Comparative, Randomized, Double-Blind Study. Journal of Pharmacology and Pharmacotherapeutics, 12(2), 54–60. https://doi.org/10.4103/jpp.jpp_8_21